ARCHIVES

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Albino African Skin Cancer Study To Be Reevaluated

April 11, 1980

Reexamine Mandates, Samuels Suggests

February 17, 1984

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013

FDA Designates Zometa For Priority Review.

November 30, 2001

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992

Breast Cancer Family History Doesn’t Increase Risk Of Ovarian Cancer, Study Says

September 30, 2005